Saturday, July 4, 2026

DTCC Teams Up With Stellar to Expand Tokenization of Traditional Financial Assets

DTCC collaborates with Stellar blockchain for asset tokenization, reflecting Wall Street's shift to blockchain for traditional finance.

North Korea’s 2026 Election: 75% New Faces in Supreme People’s Assembly – What It Means

North Korea's elections saw a historic turnover of 75% in delegates, with Kim Jong Un's influence evident in the results.

‘Despicable Me 4’ Director Reveals Why BTS-Blackpink Song Was Included in the Soundtrack

Chris Renaud, has personally explained why he chose to include songs from K-POP artists BTS and BLACKPINK in the film.

Tag: CGBIO

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

CGBio’s DCLASSY PDRN receives clinical trial approval from MFDS

CGBio's DCLASSY PDRN skin booster gains IDE approval for clinical trials targeting eye wrinkles, enhancing patient satisfaction and market competitiveness.

How ExcelOs Inject Revolutionizes Bone Grafting: Insights from the Latest GBR Seminar

CGBIO hosted a hands-on seminar for dental professionals, focusing on practical skills in maxillary sinus lifts and bone grafting techniques.

CGBio Reports Return to Operating Profit in 2025… Growth in Bone Substitutes and Dental Business

CGBio Co., Ltd. reported a $2.6M operating profit in 2025, reversing losses and achieving 36% revenue growth, driven by bone substitutes.

CGBio’s NovoFactory: A Game-Changer for Bone Graft Products in the U.S. and Japan

CGBio's new Novo Factory in Hwaseong receives approval to produce Novosis Putty, targeting advanced markets like the U.S. and Japan.

What Makes DOOTH the Game-Changer in Absorbable Sutures? Discover Its Unique Advantages!

CGBio is expanding its aesthetic business by exporting the absorbable suture DOOTH to Japan, aiming for global recognition and regulatory approvals.

K-Spine Surgery: How a Korean Firm Showcased Minimally Invasive Techniques at U.S. Conference

CGBIO successfully held a symposium on minimally invasive spinal surgery, enhancing skills of over 100 global professionals through hands-on training.

IMCAS 2026: Discover How Sijibio Secured Over 70.4 Million USD in Global Contracts

CGBIO showcased its collagen stimulator at IMCAS 2026, securing contracts worth 101.5 billion KRW to strengthen its global market position.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.